胞外囊泡携带的非编码RNA在肝癌发生、发展中的作用
收稿日期: 2019-09-16
网络出版日期: 2022-07-27
基金资助
国家自然科学基金(81773172)
Non-coding RNA within extracellular vesicle in pathogenesis of hepatocellular carcinoma
陈鹏, 李涛 . 胞外囊泡携带的非编码RNA在肝癌发生、发展中的作用[J]. 外科理论与实践, 2020 , 25(05) : 447 -451 . DOI: 10.16139/j.1007-9610.2020.05.020
| [1] | Povero D, Eguchi A, Li H, et al. Circulating extracellular vesicles with specific proteome and liver microRNAs are potential biomarkers for liver injury in experimental fatty liver disease[J]. PLoS One, 2014, 9(12):e113651. |
| [2] | Tkach M, Théry C. Communication by extracellular vesicles: where we are and where we need to go[J]. Cell, 2016, 164(6):1226-1232. |
| [3] | Luzio JP, Gray SR, Bright NA. Endosome-lysosome fusion[J]. Biochem Soc Trans, 2010, 38(6):1413-1416. |
| [4] | Takahashi K, Yan IK, Wood J, et al. Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy[J]. Mol Cancer Res, 2014, 12(10):1377-1387. |
| [5] | Zhang J, Li S, Li L, et al. Exosome and exosomal micro-RNA: trafficking, sorting, and function[J]. Genomics Pro-teomics Bioinformatics, 2015, 13(1):17-24. |
| [6] | Yu S, Cao H, Shen B, et al. Tumor-derived exosomes in cancer progression and treatment failure[J]. Oncotarget, 2015, 6(35):37151-37168. |
| [7] | Buck AH, Coakley G, Simbari F, et al. Erratum: exosomes secreted by nematode parasites transfer small RNAs to mammalian cells and modulate innate immunity[J]. Nat Commun, 2015, 6:8772. |
| [8] | Kogure T, Lin WL, Yan IK, et al. Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth[J]. Hepatology, 2011, 54(4):1237-1248. |
| [9] | Fu X, Liu M, Qu S, et al. Exosomal microRNA-32-5p induces multidrug resistance in hepatocellular carcinoma via the PI3K/Akt pathway[J]. J Exp Clin Cancer Res, 2018, 37(1):52. |
| [10] | Lee HY, Chen CK, Ho CM, et al. EIF3C-enhanced exosome secretion promotes angiogenesis and tumorigenesis of human hepatocellular carcinoma[J]. Oncotarget, 2018, 9(17):13193-13205. |
| [11] | Tu T, Budzinska MA, Maczurek AE, et al. Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development[J]. Int JMol Sci, 2014, 15(6):9422-9458. |
| [12] | Wei L, Wang X, Lv L, et al. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma[J]. Mol Cancer, 2019, 18(1):147. |
| [13] | Zhang L, Luo B, Dang YW, et al. Clinical significance of microRNA-196b-5p in hepatocellular carcinoma and its potential molecular mechanism[J]. J Cancer, 2019, 10(22):5355-5370. |
| [14] | Xu F, Yan JJ, Gan Y, et al. miR-885-5p negatively regulates Warburg effect by silencing hexokinase 2 in liver cancer[J]. Mol Ther Nucleic Acids, 2019, 18:308-319. |
| [15] | Xu Y, Huang J, Ma L, et al. MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways[J]. Cancer Lett, 2016, 371(2):171-181. |
| [16] | Hu X, Wang R, Ren Z, et al. MiR-26b suppresses hepatocellular carcinoma development by negatively regulating ZNRD1 and Wnt/beta-catenin signaling[J]. Cancer Med, 2019, 8(17):7359-7371. |
| [17] | Gao XM, Zhu Y, Li JH, et al. microRNA-26a induces a mitochondrial apoptosis mediated by p53 through targeting to inhibit Mcl1 in human hepatocellular carcinoma[J]. Onco Targets Ther, 2018, 11:2227-2239. |
| [18] | Lin XJ, Fang JH, Yang XJ, et al. Hepatocellular carcinoma cell-secreted exosomal microRNA-210 promotes angiogenesis in vitro and in vivo[J]. Mol Ther Nucleic Acids, 2018, 11:243-252.. |
| [19] | Shi M, Jiang Y, Yang L, et al. Decreased levels of serum exosomal miR-638 predict poor prognosis in hepatocellular carcinoma[J]. J Cell Biochem, 2018, 119(6):4711-4716. |
| [20] | Ke M, Zhang Z, Cong L, et al. MicroRNA-148b-colony-stimulating factor-1 signaling-induced tumor-associated macrophage infiltration promotes hepatocellular carcinoma metastasis[J]. Biomed Pharmacother, 2019, 120:109523. |
| [21] | Zhou Y, Ren H, Dai B, et al. Hepatocellular carcinoma-derived exosomal miRNA-21 contributes to tumor progression by converting hepatocyte stellate cells to cancer-associated fibroblasts[J]. J Exp Clin Cancer Res, 2018, 37(1):324. |
| [22] | Liu H, Chen W, Zhi X, et al. Tumor-derived exosomes promote tumor self-seeding in hepatocellular carcinoma by transferring miRNA-25-5p to enhance cell motility[J]. Oncogene, 2018, 37(36):4964-4978. |
| [23] | Yu FJ, Zheng JJ, Dong PH, et al. Long non-coding RNAs and hepatocellular carcinoma[J]. Mol Clin Oncol, 2015, 3(1):13-17. |
| [24] | Panzitt K, Tschernatsch MMO, Guelly C, et al. Characterization of HULC, a novel gene with striking up-regulation in hepatocellular carcinoma, as noncoding RNA[J]. Gastroenterology, 2007, 132(1):330-342. |
| [25] | Du Y, Kong G, You X, et al. Elevation of highly up-regulated in liver cancer (HULC) by hepatitis B virus X protein promotes hepatoma cell proliferation via down-regulating p18[J]. J Biol Chem, 2012, 287(31):26302-26311. |
| [26] | Iizuka N, Oka M, Yamada-Okabe H, et al. Comparison of gene expression profiles between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method[J]. Cancer Res, 2002, 62(14):3939-3944. |
| [27] | Kim KS, Lee YI. Biallelic expression of the H19 and IGF2 genes in hepatocellular carcinoma[J]. Cancer Lett, 1997, 119(2):143-148. |
| [28] | Yuan JH, Yang F, Wang F, et al. A long noncoding RNA activated by TGF-β promotes the invasion-metastasis cascade in hepatocellular carcinoma[J]. Cancer Cell, 2014, 25(5):666-681. |
| [29] | He Y, Meng XM, Huang C, et al. Long noncoding RNAs: novel insights into hepatocelluar carcinoma[J]. Cancer Lett, 2014, 344(1):20-27. |
| [30] | Yang Z, Zhou L, Wu LM, et al. Overexpression of long non-coding RNA HOTAIR predicts tumor recurrence in hepatocellular carcinoma patients following liver transplantation[J]. Ann Surg Oncol, 2011, 18(5):1243-1250. |
| [31] | Yang F, Zhang L, Huo XS, et al. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans[J]. Hepatology, 2011, 54(5):1679-1689. |
| [32] | Zhang C, Yang X, Qi Q, et al. lncRNA-HEIH in serum and exosomes as a potential biomarker in the HCV-related hepatocellular carcinoma[J]. Cancer Biomark, 2018, 21(3):651-659. |
| [33] | Li B, Mao R, Liu C, et al. LncRNA FAL11 promotes cell proliferation and migration by acting as a CeRNA of miR-1236 in hepatocellular carcinoma cells[J]. Life Sci, 2018, 197:122-129. |
| [34] | Liu T, Chi H, Chen J, et al. Curcumin suppresses prolife-ration and in vitro invasion of human prostate cancer stem cells by ceRNA effect of miR-145 and lncRNA-ROR[J]. Gene, 2017, 631:29-38. |
| [35] | Chen SY, Teng SC, Cheng TH, et al. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3[J]. Cancer Lett, 2016, 378(1):59-67. |
| [36] | Xu H, Chen Y, Dong X, et al. Serum exosomal long noncoding RNAs ENSG00000258332.1 and LINC00635 for the diagnosis and prognosis of hepatocellular carcinoma[J]. Cancer Epidemiol Biomarkers Prev, 2018, 27(6):710-716. |
| [37] | Lin J, Cao S, Wang Y, et al. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma[J]. J Exp Clin Cancer Res, 2018, 37(1):113. |
| [38] | Chen W, You J, Zheng Q, et al. Downregulation of lnc-RNA OGFRP1 inhibits hepatocellular carcinoma progression by AKT/mTOR and Wnt/β-catenin signaling pathways[J]. Cancer Manag Res, 2018, 10:1817-1826. |
| [39] | Huang JL, Cao SW, Ou QS, et al. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma[J]. Mol Cancer, 2018, 17(1):93. |
| [40] | Tang WG, Hu B, Sun HX, et al. Long non-coding RNA00364 represses hepatocellular carcinoma cell proli-feration via modulating p-STAT3-IFIT2 signaling axis[J]. Oncotarget, 2017, 8(60):102006-102019. |
| [41] | Li T, Xie J, Shen C, et al. Amplification of long noncoding RNA ZFAS1 promotes metastasis in hepatocellular carcinoma[J]. Cancer Res, 2015, 75(15):3181-3191. |
| [42] | Li T, Xie J, Shen C, et al. Upregulation of long noncoding RNA ZEB1-AS1 promotes tumor metastasis and predicts poor prognosis in hepatocellular carcinoma[J]. Oncogene, 2015, 35(12):1575-1584. |
| [43] | Kogure T, Yan IK, Lin WL, et al. Extracellular vesicle-mediated transfer of a novel long noncoding RNA TUC339: a mechanism of intercellular signaling in human hepatocellular cancer[J]. Genes Cancer, 2013, 4(7-8):261-272. |
| [44] | Takahashi K, Yan IK, Haga H, et al. Modulation of hypoxia-signaling pathways by extracellular linc-RoR[J]. J Cell Sci, 2014, 127(Pt7):1585-1594. |
| [45] | Yang J, Li C, Li H, et al. LncRNA CACNA1G-AS1 facilitates hepatocellular carcinoma progression through the miR-2392/C1orf61 pathway[J]. J Cell Physiol, 2019, 234(10):18415-18422. |
| [46] | Yin Z, Ma T, Yan J, et al. LncRNA MAGI2-AS3 inhibits hepatocellular carcinoma cell proliferation and migration by targeting the miR-374b-5p/SMG1 signaling pathway[J]. J Cell Physiol, 2019, 234(10):18825-18836. |
| [47] | Li Y, Guo D, Zhao Y, et al. Long non-coding RNA SNHG5 promotes human hepatocellular carcinoma progression by regulating miR-26a-5p/GSK3beta signal pathway[J]. Cell Death Dis, 2018, 9(9):888. |
/
| 〈 |
|
〉 |
